Control Flo Medical
Control Flo Medical, LLC was founded in 2013 and was awarded a patent for the ResQ Non-Bladder Invasive Urethral Catheter System in 2014. A second patent was granted in 2015 that states the method of use. The goal of the company is to address the global market needs of improved healthcare in treating urinary incontinence and urinary retention.
The mission of Control Flo Medical, LLC is to be God led and to serve a patient centric organization that helps others by providing solutions to the growing health problems associated with urinary incontinence and retention . It is our desire to improve the lifestyle for many, while building a valuable company that benefits others, our family, investors, and the medical community at large.
André D. Potgieter
André D. Potgieter is the Chief Executive Officer of Control Flo Medical, LLC as of January 1, 2019. With over 25 years of medical device experience, André is a proven leader with a strong sales background in spinal implants and spinal instrumentation.
Attracted by new and disruptive technologies, early stage medical device companies and building new organizations is his passion. From 2007-2016 André served as Executive Vice President, US Sales for LDR Spine, Inc. where the company executed the largest US clinical IDE trial in spine, leading to the approval of Mobi-C (the first 1 and 2 level artificial disc in the US for the treatment of degenerative cervical disc disease). LDR was acquired by Zimmer Biomet in 2016 for $1B. Prior to LDR, André held various sales and sales management positions with increasing responsibility at Kyphon, Inc. from 1999-2007. Kyphon developed Balloon Kyphoplasty for the treatment of VCFs (Vertebral Compression Fractures as a result of cancer and/or osteoporosis) and utilized a minimally invasive cavity creation technique and bone cement to create an “internal cast” to treat the fractured vertebrae(s). Kyphon was acquired by Medtronic for $4.4B in 2007. From 1993-1999, André spent 8 years in the operating room as a sales professional with Synthes Spine, Inc.
André resides in Austin, TX and holds a B.S. in Business Administration, Finance, from the University of Tennessee in Knoxville.
Al Barnett, founder of Control Flo Medical, LLC, is the inventor of the ResQ Urethral Catheter System. A long-term patient of urinary problems, Mr. Barnett devised a “homemade” non-bladder invasive catheter in order to help people eliminate daily dilations and potential pain, as well as the self-consciousness associated with urinary problems. He obtained two patents and began to build a company that has achieved important milestones to grow the company in profound ways.
Mr. Barnett is the majority owner of Control Flo Medical, LLC and has a B.S. in Business Administration from Auburn University, Auburn Alabama.
Philip A. White
Philip A. White is the Chief Operations Officer of Control Flo Medical, LLC with experience spanning over 15 years. His advanced skills include focusing on new innovations in technology and medical products, business development, IP expansion, regulatory compliance, clinical research, and capital funding. He is a recognized leader with in-depth knowledge of health care, medical devices, pharmaceuticals, and physician and patient services.
Philip is talented in setting a vision and mission for the companies he works and excels in achieving goals as evidenced by his leadership in taking a company public on the Bermuda Stock Exchange and dual listing that stock in Frankfurt and Berlin. He has an extensive network of experts from product concept to commercial launch, previously serving as CEO with Saba Labs, LLC. and Neomedigen Limited.
Philip served in the U.S. Navy/ Marine Corp and studied Business Management at Auburn University Montgomery.
Arthur M. Britton, MD
Medical Advisor OB/GYN
Dr. Arthur Britton is a partner in product development of the ResQ Catheter. Dr. Britton completed undergraduate studies at Emory University, Atlanta, Georgia and received his medical degree from the University Of Alabama School Of Medicine in Birmingham, Alabama. He completed his residency at the University of South Alabama Obstetrics and Gynecology in Mobile, Alabama. Dr. Britton’s private practice as a board certified Obstetrician-Gynecologist spans from 1977 – 2013, providing a broad range of services for patients experiencing urinary incontinence and other difficulties related to pelvic and urethral problems. Dr. Britton remains actively involved in the practice of medicine at Baptist Health Hospitals in Montgomery, Alabama.
George Adams, MD
chief medical officer urology
Dr. George Adams is the Chief Medical Officer Urology in research and product development of the ResQ Catheter. He is a graduate of the University of Alabama and obtained his medical degree from the University of Alabama School of Medicine in Birmingham in 1965. Dr. Adams went on to complete an internship in general surgery and residency in Urology at Carraway Methodist Medical Center in 1974. He became board certified in Urology in 1976 and has authored several publications on the subject of Benign Prostatic Hyperplasia and Hormone Resistant Prostate Cancer. Dr. Adams has conducted clinical research from 1981 through 2014 for Urology Centers of Alabama located in Birmingham.
Jim Richardson, MD
Dr. Jim Richardson is a medical advisor in patient care and product development of the ResQ Catheter. Dr. Richardson completed undergraduate studies and received his medical degree from Louisiana State University and later completed his residency at the University of Alabama in Birmingham. Dr. Richardson began practicing medicine in 1980 and has held a number of board, clinical and academic positions. He is the Facility Medical Director for Team Health, as well as a physician at Vaughn Regional Medical Center. Dr. Richardson is credited with over 60 juried publications, abstracts, and presentations and is referenced in Cardiac Surgery by John W. Kirklin, M.D. and Sir Brian Barrett-Boyes.